ARCHIVES

Scientists Defend NCI, Criticize Post Series As Inaccurate

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

Mammography Guidelines Tightened For BCDDP; September Consensus Meeting Planned

May 13, 1977

R01 Grants Pool, New Investigators Hit By Budget Strains

October 27, 1989